{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:15Z","timestamp":1791223635439,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["F31HL143913"],"award-info":[{"award-number":["F31HL143913"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["F32HL145914"],"award-info":[{"award-number":["F32HL145914"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["P01HL134608"],"award-info":[{"award-number":["P01HL134608"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL123966"],"award-info":[{"award-number":["R01HL123966"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL136954"],"award-info":[{"award-number":["R01HL136954"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01HL142271"],"award-info":[{"award-number":["R01HL142271"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20EIA35320226"],"award-info":[{"award-number":["20EIA35320226"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jacbts.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T14:04:54Z","timestamp":1629727494000},"page":"650-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Molecular Signature of HFpEF"],"prefix":"10.1016","volume":"6","author":[{"given":"Andrew A.","family":"Gibb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh T.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanendra","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne F.","family":"Garbincius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin W.","family":"Kolmetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remus M.","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Houser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Elrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.07.004_bib1","series-title":"National Clinical Guideline Centre (UK). Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update [Internet].","year":"2010"},{"key":"10.1016\/j.jacbts.2021.07.004_bib2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.07.004_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib5","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","author":"Reddy","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2021.07.004_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.07.004_bib10","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2021.07.004_bib11","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","article-title":"Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart\u00a0Failure)","volume":"53","author":"van Veldhuisen","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2021.07.004_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.hfc.2014.04.011","article-title":"Clinical trials in patients with heart failure and preserved left ventricular ejection fraction","volume":"10","author":"Cleland","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacbts.2021.07.004_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","article-title":"Animal models of heart failure with preserved ejection fraction","volume":"24","author":"Conceicao","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jacbts.2021.07.004_bib16","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1038\/s41598-017-15851-2","article-title":"A\u00a0feline HFpEF model with pulmonary hypertension and compromised pulmonary function","volume":"7","author":"Wallner","year":"2017","journal-title":"Sci Rep"},{"issue":"525","key":"10.1016\/j.jacbts.2021.07.004_bib17","doi-asserted-by":"crossref","first-page":"eaay7205","DOI":"10.1126\/scitranslmed.aay7205","article-title":"HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction","volume":"12","author":"Wallner","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2021.07.004_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-018-5213-9","article-title":"Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure","volume":"19","author":"Sweet","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jacbts.2021.07.004_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2460\/ajvr.73.2.202","article-title":"Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy","volume":"73","author":"Riesen","year":"2012","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.jacbts.2021.07.004_bib23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.echo.2010.06.010","article-title":"Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography","volume":"23","author":"Russo","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacbts.2021.07.004_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0002-9149(99)00876-0","article-title":"Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function","volume":"85","author":"Mattioli","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jsap.12186","article-title":"Left atrial size, atrial function and left ventricular diastolic function in cats with hypertrophic cardiomyopathy","volume":"55","author":"Linney","year":"2014","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.jacbts.2021.07.004_bib26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.117.028274","article-title":"Exercise-induced changes in glucose metabolism promote physiological cardiac growth","volume":"136","author":"Gibb","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.118.034822","article-title":"DNA damage response mediates pressure overload-induced cardiomyocyte hypertrophy","volume":"139","author":"Nakada","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib28","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1074\/jbc.M110.171975","article-title":"ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function","volume":"286","author":"Darshi","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.07.004_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2021.07.004_bib31","doi-asserted-by":"crossref","first-page":"c108","DOI":"10.1159\/000078639","article-title":"Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase","volume":"97","author":"El Nahas","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jacbts.2021.07.004_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cvr\/cvr015","article-title":"Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy","volume":"90","author":"Abel","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1074\/jbc.RA117.000444","article-title":"Glutaminolysis is required for transforming growth factor-beta1-induced myofibroblast differentiation and activation","volume":"293","author":"Bernard","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.07.004_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2017-0238OC","article-title":"Glutaminolysis promotes collagen translation and stability via alpha-ketoglutarate-mediated mTOR activation and proline hydroxylation","volume":"58","author":"Ge","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.jacbts.2021.07.004_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","article-title":"Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts","volume":"61","author":"Hamanaka","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib37","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/s41467-019-12103-x","article-title":"Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation","volume":"10","author":"Lombardi","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jacbts.2021.07.004_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/ijms21010229","article-title":"Food-derived collagen peptides, prolyl-hydroxyproline (Pro-Hyp), and hydroxyprolyl-glycine (Hyp-Gly) enhance growth of primary cultured mouse skin fibroblast using fetal bovine serum free from hydroxyprolyl peptide","volume":"21","author":"Asai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2021.07.004_bib39","doi-asserted-by":"crossref","first-page":"548975","DOI":"10.3389\/fcell.2020.548975","article-title":"Collagen-derived di-peptide, prolylhydroxyproline (Pro-Hyp): a new low molecular weight growth-initiating factor for specific fibroblasts associated with wound healing","volume":"8","author":"Sato","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A\u00a0branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance","volume":"22","author":"Jang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2021.07.004_bib41","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2337\/db19-1174","article-title":"3-Hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism","volume":"69","author":"Nilsen","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jacbts.2021.07.004_bib42","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1073\/pnas.1206868109","article-title":"Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity","volume":"109","author":"Timmers","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.07.004_bib43","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib44","doi-asserted-by":"crossref","first-page":"29881","DOI":"10.1074\/jbc.M114.601864","article-title":"Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure","volume":"289","author":"Liu","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2021.07.004_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yjmcc.2010.11.009","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","volume":"51","author":"McKinsey","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.jacbts.2021.07.004_bib47","first-page":"e84897","article-title":"Mitochondrial protein hyperacetylation in the failing heart","volume":"2","author":"Horton","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2021.07.004_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCGENETICS.110.957571","article-title":"Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure","volume":"4","author":"Barth","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacbts.2021.07.004_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvp344","article-title":"Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure","volume":"85","author":"Bugger","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2021.07.004_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2005.08.002","article-title":"Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure","volume":"40","author":"Gao","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib51","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury","volume":"25","author":"Li","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacbts.2021.07.004_bib53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamacardio.2017.2511","article-title":"Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome","volume":"2","author":"Schelbert","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib54","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","article-title":"Cardiomyocyte stiffness in diastolic heart failure","volume":"111","author":"Borbely","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jcmg.2014.04.022","article-title":"CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF","volume":"7","author":"Su","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacbts.2021.07.004_bib57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib58","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","article-title":"Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness","volume":"124","author":"Falcao-Pires","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.07.004_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2012.11.008","article-title":"Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway","volume":"55","author":"Lauzier","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/eurjhf\/hfr067","article-title":"Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure","volume":"13","author":"Hartog","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","article-title":"The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure","volume":"11","author":"Little","year":"2005","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib63","first-page":"416","article-title":"Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure","volume":"60","author":"Dai","year":"2012","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib64","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/eurjhf\/hfr079","article-title":"Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?","volume":"13","author":"Collier","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1479-5876-9-150","article-title":"Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man","volume":"9","author":"Boyle","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jacbts.2021.07.004_bib66","doi-asserted-by":"crossref","first-page":"E3901","DOI":"10.1073\/pnas.1523512113","article-title":"OX40L blockade protects against inflammation-driven fibrosis","volume":"113","author":"Elhai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.07.004_bib67","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1152\/ajpendo.00142.2010","article-title":"{beta}-Hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle","volume":"299","author":"Yamada","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.07.004_bib68","doi-asserted-by":"crossref","first-page":"e15092","DOI":"10.7554\/eLife.15092","article-title":"Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body beta-hydroxybutyrate","volume":"5","author":"Sleiman","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.jacbts.2021.07.004_bib69","article-title":"Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction: the Multi-Ethnic Study of Atherosclerosis","volume":"6","author":"O'Neal","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.07.004_bib70","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","article-title":"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart\u00a0Failure Long-Term Registry","volume":"39","author":"Zafrir","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacbts.2021.07.004_bib71","doi-asserted-by":"crossref","first-page":"H1935","DOI":"10.1152\/ajpheart.00061.2021","article-title":"Single cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome","volume":"320","author":"Tambi","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib72","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/s41467-019-12721-5","article-title":"Identification of atrial fibrillation associated genes and functional non-coding variants","volume":"10","author":"van Ouwerkerk","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2021.07.004_bib73","doi-asserted-by":"crossref","first-page":"H1364","DOI":"10.1152\/ajpheart.00004.2014","article-title":"Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"306","author":"Kitzman","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2021.07.004_bib74","first-page":"636","article-title":"Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance","volume":"4","author":"Molina","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"7","key":"10.1016\/j.jacbts.2021.07.004_bib75","doi-asserted-by":"crossref","first-page":"e004129","DOI":"10.1161\/CIRCHEARTFAILURE.117.004129","article-title":"Fatigability, exercise intolerance, and abnormal skeletal muscle energetics in heart failure","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.jacbts.2021.07.004_bib76","doi-asserted-by":"crossref","first-page":"e004281","DOI":"10.1161\/CIRCHEARTFAILURE.117.004281","article-title":"Making the case for skeletal muscle myopathy and its contribution to exercise intolerance in heart failure with preserved ejection fraction","volume":"10","author":"Kitzman","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2021.07.004_bib77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease","volume":"518","author":"Gjoneska","year":"2015","journal-title":"Nature"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21002369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:23:13Z","timestamp":1762820593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X21002369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2452302X21002369"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.004","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Signature of HFpEF","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}